ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

EMEND Improved Emesis In Men And Women, Trials Find

December 26, 2003

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Kaiser Foundation Offers Community Health Grants

April 18, 1986

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Cancer Meetings Listed

March 26, 1993

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992